This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Astrazeneca Ab. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Anna Tomberg: Pharmaceutical Patent Inventor
Introduction
Anna Tomberg is an inventor based in Gothenburg, Sweden. Her patent work concerns pharmaceutical compounds and their potential use in treating or preventing conditions mediated by prolyl endopeptidase fibroblast activation protein (FAP). She is associated with AstraZeneca AB and is credited with 1 patent.
Latest Patents
Tomberg is named on a patent titled “N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)-quinoline-4-carboxamides.” The patent describes compounds of Formula (I), their pharmaceutically acceptable salts, pharmaceutical compositions, and kits. It also covers the use of these compounds and salts to treat or prevent FAP-mediated conditions, as well as methods for manufacturing them.
Career Highlights
The available information connects Tomberg’s patent activity with AstraZeneca AB and pharmaceutical research. Her listed invention focuses on compounds with potential therapeutic applications.
Collaborations
Tomberg’s listed coworkers include Daniel Laurent Knerr and Maria Johansson.
Conclusion
Anna Tomberg’s patent record reflects work on pharmaceutical compounds and potential treatments for FAP-mediated conditions, in connection with AstraZeneca AB.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile